Nandrolone Decanoate Norma 100 mg/ml
- Pickup from New Mail
- New Mail Courier
- Pickup from the store
- Other transport services
- Cash upon receipt
- Bank transfer
- Privat 24
- WebMoney
Nandrolone Decanoate NORMA 100 mg/ml — 1 Vial
- Brand: Norma
- Category: Injectable 19-nor AAS (Research Only)
- Strength: 100 mg/ml · 2 ml (200 mg total)
- Manufactured in: Greece
Product Overview
- Nandrolone Decanoate NORMA is an oil-based injectable preparation of nandrolone, a
- 19-nortestosterone-derived anabolic agent with a high anabolic-to-androgenic ratio and a prolonged
- release profile due to its decanoate ester. It is widely used in research models examining
- muscle wasting, nitrogen retention, erythropoiesis, bone density, depot kinetics, and endocrine
- responses. Supplied strictly for laboratory research only.
Key Research Highlights
High anabolic index:
Literature estimates nandrolone’s anabolic:androgenic ratio at ~11:1 compared with testosterone’s 1:1.
Depot pharmacokinetics:
Decanoate ester produces slow-release IM kinetics with a reported half-life of ~6–12 days.
Myotrophic & hematologic properties:
Increases nitrogen retention, stimulates protein synthesis, and enhances erythropoiesis.
Bone density & anti-wasting research:
Frequently evaluated in models of cachexia, osteoporosis, chronic disease, and HIV-associated wasting.
Suggested Laboratory Applications
- Muscle-wasting and cachexia models
- Protein synthesis & nitrogen-balance assays
- Bone mineral density investigations
- Erythropoiesis & hematologic studies
- Depot-kinetics and slow-release pharmacology research
- Androgen receptor–mediated transcription experiments
Technical Specifications
| Field | Data |
|---|---|
| Active Compound | Nandrolone Decanoate |
| Compound Class | Anabolic-androgenic steroid (19-nor testosterone derivative) |
| Form | Oil-based injectable solution |
| Strength | 100 mg per ml |
| Total Content | 2 ml vial ( 200 mg nandrolone decanoate) |
| Route (Research Context) | Intramuscular depot injection |
| Ester | Decanoate (long-chain, slow release) |
| Receptor Activity | High-affinity androgen receptor agonist; strong myotrophic activity |
| Excipients (Label) | Benzyl alcohol, arachis (peanut) oil |
| Brand | Norma |
| Country of Origin | Greece |
| Pack | 1 vial |
| Price | €10 |
| Research Background & Findings | Improved lean mass and strength in catabolic or hypogonadal models |
| Enhanced nitrogen retention and protein synthesis pathways | Positive effects on bone mineral density in some clinical research |
| Increased red blood cell mass and hemoglobin levels | Depot-release kinetics useful for studying long-acting androgen exposure |
Documented Research Side Effects
- Suppression of endogenous testosterone & fertility markers (HPG-axis suppression)
- Adverse lipid changes (HDL, LDL) & potential cardiovascular strain
- Possible neurobehavioral alterations under chronic exposure
- Estrogen-related effects (via aromatization): fluid retention, gynecomastia
- Androgenic signals: acne, oily skin, hair changes
- Injection-site irritation from oil depot
Handling & Compliance
For Research Use Only — not for human or veterinary application.
Nandrolone and its esters are WADA-prohibited S1 anabolic agents and are controlled substances in many jurisdictions.
Researchers must follow all local regulations, chemical-handling SOPs, and ethical guidelines.
-
Package:2 ml vial (≈ 200 mg nandrolone decanoate)
-
Concentration:100 mg per ml
-
Form:Oil-based injectable solution
-
Country of manufacture:Greece